Академический Документы
Профессиональный Документы
Культура Документы
FSH & LH
Interpretation
--------------------------------------------------------------
| REFERENCE GROUP | REFERENCE RANGE IN mIU/mL |
|----------------------------------|---------------------------|
| Adult Females | |
| Follicular | 2.50 - 10.20 |
| Mid Cycle Peak | 3.40 - 33.40 |
| Luteal Phase | 1.50 - 9.10 |
| Post Menopausal | 23.00 - 116.30 |
| Pregnant | < 0.30 |
--------------------------------------------------------------
Clinical Use
· Diagnosis of gonadal function disorders
· Management and treatment of infertility in both genders
Increased levels
· Primary hypogonadism
· Gonadotropin secreting pituitary tumors
· Menopause
Decreased levels
· Hypothalamic GnRH deficiency
· Pituitary FSH deficiency
· Ectopic steroid hormone production
Interpretation
--------------------------------------------------------------
| REFERENCE GROUP | REFERENCE RANGE IN mIU/mL |
|----------------------------------|---------------------------|
| Adult Females | |
| Follicular | 1.90 - 12.50 |
| Mid Cycle Peak | 8.70 - 76.30 |
| Luteal Phase | 0.50 - 16.90 |
| Post Menopausal | 15.90 - 54.00 |
| Pregnant | 0.10 - 1.50 |
| Oral Contraceptives | 0.70 - 5.60 |
PatientReportSCSuperPanel.SP_GENERAL_TEMPLATE01_SC (Version: 7)
*138263226* Page 1 of 4
.
Clinical Use
· Diagnosis of gonadal function disorders
· Diagnosis of pituitary disorders
Increased levels
· Primary hypogonadism
· Gonadotropin secreting pituitary tumors
· Menopause
· Luteal phase of menstrual cycle
· Polycystic ovarian disease
Decreased levels
· Hypothalamic GnRH deficiency
· Pituitary LH deficiency
· Ectopic steroid hormone production
· GnRH analog treatment
PatientReportSCSuperPanel.SP_GENERAL_TEMPLATE01_SC (Version: 7)
*138263226* Page 2 of 4
.
Note: 1. A single random blood sample for insulin may provide insufficient information due to wide variation in
the time responses of insulin levels and blood glucose.
2. Stimulation of insulin secretion may be caused by many factors like hyperglycemia, glucagon, amino
acids, growth hormone and catecholamines.
3. Interference in insulin assay is seen due to insulin antibodies which develop in patients treated with
bovine or porcine insulin.
Clinical Utility
· Evaluation of fasting hypoglycemia
· Evaluation of Polycystic Ovary syndrome
· Classification of Diabetes mellitus
· Predict Diabetes mellitus
· Assessment of Beta cell activity
· Select optimal therapy for Diabetes
· Investigation of insulin resistance
· Predict the development of Coronary Artery Disease
Increased Levels- Insulinoma, Some Type II diabetic patients, Infantile hypoglycemia, Hyperinsulinism,
Obesity, Cushing’s syndrome, Oral contraceptives, Acromegaly, Hyperthyroidism
Decreased Levels- Untreated Type I Diabetes mellitus
Result/s to follow:
HEMOGLOBIN HPLC/ELECTROPHORESIS
PatientReportSCSuperPanel.GENERAL_PANEL_ANALYTE_SC (Version: 6)
*138263226* Page 3 of 4
.
IMPORTANT INSTRUCTIONS
*Test results released pertain to the specimen submitted .*All test results are dependent on the quality of the sample received by the Laboratory .
*Laboratory investigations are only a tool to facilitate in arriving at a diagnosis and should be clinically correlated by the Referring Physician .*Sample
repeats are accepted on request of Referring Physician within 7 days post reporting.*Report delivery may be delayed due to unforeseen
circumstances. Inconvenience is regretted.*Certain tests may require further testing at additional cost for derivation of exact value. Kindly submit
request within 72 hours post reporting.*Test results may show interlaboratory variations .*The Courts/Forum at Delhi shall have exclusive
jurisdiction in all disputes/claims concerning the test(s) & or results of test(s).*Test results are not valid for medico legal purposes. * Contact
customer care Tel No. +91-11-39885050 for all queries related to test results.
PatientReportSCSuperPanel.GENERAL_PANEL_ANALYTE_SC (Version: 6)
*138263226* Page 4 of 4